J&J to land Synthes for $20bn?
This article was originally published in Scrip
Executive Summary
Johnson & Johnson is negotiating a takeover bid for orthopaedic specialist Synthes in an effort to diversify its healthcare business and strengthen its presence in the orthopaedic trauma market.